Skip to content
★ Sign in to follow
BB

Beijing Balance Medical Technology Co.,Ltd. Stock: price and insider trades · China

佰仁医疗

CN·Mcap CN¥9.7BHealth Care

No insider purchase over the last 90 days. The latest, by 金磊, was filed 02 Jan 2025.

Beijing Balance Medical Technology Co.,Ltd.: what insiders have been doing

Beijing Balance Medical Technology Co.,Ltd. belongs to the Health Care sector. Filings by its managers are published through SSE / SZSE (CSRC). No insider at Beijing Balance Medical Technology Co.,Ltd. has published a filing in the past twelve months. The most recent one dates from 2 January 2025.

Since 2021, the database holds 6 purchases and 12 sales by insiders of the company.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.

Insider Decl.
18
Thresholds
n/a
Buy Volume
€901,932
6 ops. · all time
Sell Volume
€290,659
12 ops. · all time

Who traded when

BuySale
吴嘉3 sales
金磊1 buy

Since the insiders bought

  • Filed 02 Jan 2025 · 677 days ago · €215k
    +3.1%
    Entry CN¥107.01 · Close at T+365 CN¥110.36

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 9,937 of 26,911 companies
58.0
score / 100
Value
31
Quality
85
FCF yld0.6%
Earn yld2.0%
EV/EBITDA39.1x
ROE13%
Gross mgn89%
Net mgn31%
Debt/EBITDA0.4x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥70.19
Analyst consensus
1 analysts
1.00/5
CN¥106.00Target CN¥106.00(+51%)CN¥106.00
Income statement
RevenueCN¥620.2M
Gross profitCN¥553.1M89% margin
EBITDACN¥249.7M40% margin
Net incomeCN¥193.6M26.5% margin
Valuation
PER (trailing)56.2x
P/Book7.7x
Beta0.02
Balance sheet & cash
Market capCN¥9.7B
Total debtCN¥93.6M
Free Cash FlowCN¥61.6M
Debt / Equity5%
Profitability & ownership
ROE12.8%
ROA6.4%
% insiders73.3%
% institutions8.1%
Last declaration on 2 January 2025
Declarations18 total
  • ▲
    董事,高级管理人员,核心技术人员Executives
    2M CNY9SSE
    15,200 shares23.9% of flowA股XSHGSSE:173000008396299330
    Canonical exit: 2 Apr 2025 (T+90)
  • ▼
    核心技术人员Executives
    168,000 CNY3SSE
    1,500 shares10.7% of flowA股XSHGSSE:173000008377200740
  • ▼
    核心技术人员Executives
    304,668 CNY4SSE
    2,604 shares18.7% of flowA股XSHGSSE:173000008362519260
  • ▼
    核心技术人员Executives
    243,082 CNY4SSE
    2,000 shares15.0% of flowA股XSHGSSE:173000008342197060
  • ▲
    董事,高级管理人员,核心技术人员Executives
    1M CNY9SSE
    12,000 shares20.3% of flowA股XSHGSSE:173000008276334940
    Canonical exit: 16 Feb 2025 (T+90)
  • ▼
    核心技术人员Executives
    48,502 CNY3SSE
    500 shares9.7% of flowA股XSHGSSE:173000008115074600
  • ▼
    核心技术人员Executives
    309,240 CNY4SSE
    3,000 shares18.8% of flowA股XSHGSSE:173000007779597020
  • ▼
    核心技术人员Executives
    211,575 CNY6SSE
    1,500 shares43.3% of flowA股XSHGSSE:173000007105043170
  • ▼
    核心技术人员Executives
    231,320 CNY19SSE
    2,000 shares47.0% of flowA股XSHGSSE:173000006758729660
  • ▼
    核心技术人员Executives
    93,104 CNY3SSE
    800 shares5.5% of flowA股XSHGSSE:173000006747735740
  • ▼
    核心技术人员Executives
    136,000 CNY10SSE
    1,000 shares100.0% of flowA股XSHGSSE:173000005986370750
  • ▼
    核心技术人员Executives
    251,800 CNY4SSE
    2,000 shares17.5% of flowA股XSHGSSE:173000005730496320
  • ▲
    董事,高级管理人员,核心技术人员Executives
    1M CNY9SSE
    10,000 shares18.9% of flowA股XSHGSSE:173000005588899000
    Canonical exit: 11 Sept 2022 (T+90)
  • ▲
    董事,高级管理人员,核心技术人员Executives
    1M CNY9SSE
    9,100 shares18.0% of flowA股XSHGSSE:173000005578585860
    Canonical exit: 5 Sept 2022 (T+90)
  • ▲
    董事,高级管理人员,核心技术人员Executives
    471,913 CNY8SSE
    3,716 shares7.3% of flowA股XSHGSSE:173000005573936450
    Canonical exit: 4 Sept 2022 (T+90)
  • ▲
    董事,高级管理人员,核心技术人员Executives
    751,654 CNY8SSE
    6,084 shares11.6% of flowA股XSHGSSE:173000005560699740
    Canonical exit: 29 Aug 2022 (T+90)
  • ▼
    核心技术人员Executives
    158,105 CNY3SSE
    1,000 shares10.7% of flowA股XSHGSSE:173000005426679940
  • ▼
    核心技术人员Executives
    48,998 CNY2SSE
    200 shares3.1% of flowA股XSHGSSE:173000005426679900

18 of 18 declarations

About Beijing Balance Medical Technology Co.,Ltd.

佰仁医疗 is a company in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and commercialization of innovative medical solutions.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations